An Atlanta-based private equity and venture capital firm founded in 1983 that targets early to growth-stage technology and healthcare companies in the United States, with a focus on the Southeast and Georgia. It invests across seed, startup, early and late venture, emerging growth and growth capital, and seeks to take board seats in portfolio companies. The firm focuses on software, information technology, internet security, cloud services, SaaS, data analytics, fintech and payment technologies, as well as healthcare infrastructure, health IT, revenue cycle management, telemedicine and care management platforms. It generally backs companies with roughly $2 million to $20 million in revenue and invests about $6 million to $10 million per deal. Noro-Moseley prefers opportunities headquartered in Georgia and nearby states such as Florida, North Carolina, Texas and others in the Southeast and beyond. It does not invest in pure drug development opportunities.
Liminal is an independent identity research and strategy company that specializes in digital commerce and infrastructure. The firm assists businesses, investors, and governments in navigating market trends to develop sustainable and innovative identity-enabled products and strategies. Liminal fosters community engagement and dialogue through initiatives like the KNOW Identity Conferences, while also providing educational content, news, and media services to support its clientele.
Datasembly
Series B in 2023
Founded in 2014, Datasembly specializes in transforming unstructured web data into structured data. It aggregates millions of grocery and retail pricing records daily from various sources, providing valuable insights to CPG brands, retailers, and analytics firms for informed business decisions.
Trilliant Health
Series A in 2018
Founded in 1989, Trilliant Health is an analytics and data science company specializing in intelligent patient acquisition solutions. It synthesizes all-payer claims, household, and patient-generated data to provide insights for maximizing market share.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.